4//SEC Filing
Gaal Lubor 4
Accession 0001104659-21-089395
CIK 0001504167other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:06 PM ET
Size
5.9 KB
Accession
0001104659-21-089395
Insider Transaction Report
Form 4
Gaal Lubor
Director
Transactions
- Award
Stock Option (right to buy)
2021-07-01+71,893→ 71,893 totalExercise: $1.18Exp: 2031-07-01→ Common Stock, par value $0.001 per share (71,893 underlying)
Footnotes (2)
- [F1]The option grant was approved by the compensation committee of the board of directors of Timber Pharmaceuticals, Inc. (the "Company") on April 21, 2021, subject to stockholder approval of an amendment to the Company's 2020 Omnibus Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on July 1, 2021.
- [F2]The option grant will vest in 24 equal monthly installments beginning on August 1, 2021.
Documents
Issuer
Timber Pharmaceuticals, Inc.
CIK 0001504167
Entity typeother
Related Parties
1- filerCIK 0001822638
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:06 PM ET
- Size
- 5.9 KB